Pharmacognosy Journal Impact Factor & Information
Current impact factor: 0.00
Impact Factor Rankings
Publications in this journal
Pharmacognosy Journal 01/2015; 7(2):97-101. DOI:10.5530/pj.2015.2.3
Pharmacognosy Journal 01/2015; 7(2):83-88. DOI:10.5530/pj.2015.2.1
Pharmacognosy Journal 01/2015; 7(2):117-123. DOI:10.5530/pj.2015.2.6
Pharmacognosy Journal 01/2015; 7(2):107-116. DOI:10.5530/pj.2015.2.5
[Show abstract] [Hide abstract]
ABSTRACT: Aim:Valeriana hardwickii Wall. belongs to family Valerianaceae grown in high altitude areas of north west Himalaya to Bhutan. Traditionally, the roots of the plant are used to treat insomnia; however, no reports are available regarding any pharmacognostic work on this plant. Material and Methods: The study includes morphological, microscopic and preliminary phytochemical investigations of the roots and rhizome. Anatomical studies of roots and rhizome shows the presence of diagnostic characters such as thick walled cortex cells, annular xylem fi ber, pitted xylem vessel and rhizome hair. Results: The preliminary phytochemical screening of petroleum ether, dichlomethane and aqueous extract revealed the presence of tritepenoids, alkaloids, irridoidal glycosides and fl avanoids. The study was carried out as per WHO guidelines. Conclusion: The outcome of this work will help the researchers to differentiate V. hardwickii from the other species of valerianPharmacognosy Journal 10/2014; 6(5):33-36.
[Show abstract] [Hide abstract]
ABSTRACT: Objective: In this study anti-tubercular (Anti-TB) drugs (isoniazid [INH] and rifampicin [RMP]) induced liver toxicity has been studied for the hepatoprotective effect of hydroethanolic extract of Calotropis procera (CP) flowers in rats. Materials and Methods: Animals were divided into four groups, group A was given normal saline (1 ml/kg), group B received INH (50 mg/kg) and RMP (100 mg/kg) group C received INH (50 mg/kg), RMP (100 mg/kg) and CP (150 mg/kg) orally for 14 days. Results: Biochemical markers of liver toxicity such as aspartate aminotransferase (AST), alanine transaminase (ALT), alkaline phosphatase (ALP), and bilirubin and tissue histology were done inall groups. Anti-TB drugs (INH 50 mg/kg and RMP 100 mg/kg) have enhanced the ALT, AST, ALP, bilirubin and histological changes in liver, whereas co-administration of anti-TB drugs with CP has reduced these levels within the normal range. Conclusion: Findings of this study showed the hepatoprotective effect of CP against INH and RMP administration to reduce the liver damage for chronic treatment.Pharmacognosy Journal 09/2014; 6(5):9. DOI:10.5530/pj.2014.5.3
Pharmacognosy Journal 07/2014; 6(5):1-4. DOI:10.5530/pj.2014.5.1
Pharmacognosy Journal 07/2014; 6(5):63-65. DOI:10.5530/pj.2014.5.11
Pharmacognosy Journal 07/2014; 6(5):37-46. DOI:10.5530/pj.2014.5.8
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.